We are live on ! Find out more
DARE icon

Dare Bioscience

38 hedge funds and large institutions have $13.7M invested in Dare Bioscience in 2021 Q4 according to their latest regulatory filings, with 6 funds opening new positions, 12 increasing their positions, 5 reducing their positions, and 7 closing their positions.

New
Increased
Maintained
Reduced
Closed

140% more repeat investments, than reductions

Existing positions increased: 12 | Existing positions reduced: 5

123% more capital inflows, than outflows

Capital inflows: $3.05M | Capital outflows: $1.37M

3% more funds holding

Funds holding: 37 → 38 (+1)

2.12% more ownership

Funds ownership: 6.85% → 8.97% (+2.1%)

14% less first-time investments, than exits

New positions opened: 6 | Existing positions closed: 7

50% less funds holding in top 10

Funds holding in top 10: 2 → 1 (-1)

Holders
38
Holders Change
+1
Holders Change %
+2.7%
% of All Funds
0.58%
Holding in Top 10
1
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-50%
% of All Funds
0.02%
New
6
Increased
12
Reduced
5
Closed
7
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

DARE Hedge Fund Activity: Q4 2021 in Review

38 of the 6,518 institutional investors tracked by Wall St. Rank reported a position in Dare Bioscience (DARE) for Q4 2021, worth a combined $13.7M — up 70% from $8.07M a quarter earlier.

Sellers outnumbered buyers: 7 funds closed out of DARE and 6 opened new positions — a net loss of 1 holder — while 5 trimmed existing stakes and 12 added.

The largest buyer was Vanguard Group, adding an estimated $1.53M. The largest seller was Renaissance Technologies, exiting entirely with an estimated $541K sold.

  • 38 institutional investors held Dare Bioscience (DARE) as of Q4 2021, up from 37 in Q3 2021.
  • Funds reported $13.7M of Dare Bioscience stock for Q4 2021, up 70% quarter-over-quarter.
  • 6 funds opened new Dare Bioscience positions in Q4 2021 and 7 closed out, a net change of -1 holder.
  • The largest Dare Bioscience buyer in Q4 2021 was Vanguard Group, an estimated $1.53M added.
  • The largest Dare Bioscience seller in Q4 2021 was Renaissance Technologies, an estimated $541K sold.

Based on aggregated 13F filings for Q4 2021.